Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients
- 1 July 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (1), 156-166
- https://doi.org/10.1046/j.1523-1755.2001.00782.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mycophenolate mofetil: therapeutic applications in kidney transplantation and immune-mediated renal diseaseCurrent Opinion in Nephrology and Hypertension, 1999
- DIFFERENTIAL EXPRESSION OF T-CELL GROWTH FACTORS IN REJECTING MURINE ISLET AND HUMAN RENAL ALLOGRAFTSTransplantation, 1998
- The Role of T-Cell Costimulatory Activation Pathways in Transplant RejectionNew England Journal of Medicine, 1998
- Chronic renal transplant lossKidney International, 1995
- THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2Transplantation, 1994
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- TRANSPLANTATION IN THE NINETIES1Transplantation, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.Journal of Histochemistry & Cytochemistry, 1990